Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 105

Sort by

Sort Order Select

Journal Articles

Cytoplasmic but not nuclear cleaved gsdmd expression in live macrophages and DLBCL cells marks proinflammatory cognate interactions rather than pyroptosis and predicts better patient survival in DLBCL

Blood (2025) 146 (Supplement 1): 7079.

https://doi.org/10.1182/blood-2025-7079

Published: 2025

Journal Articles

The efficacy and safety of orelabrutinib-based regimens in the treatment of marginal zone lymphoma: A retrospective real-world study

Shunfeng Hu, Beibei Lv, Ya Zhang, Yujie Jiang, Peipei Li, Ken H. Young, Xiaosheng Fang

Blood (2025) 146 (Supplement 1): 7111.

https://doi.org/10.1182/blood-2025-7111

Published: 2025

Journal Articles

Race-related molecular differences in SLAMF7 expression drive disparities in multiple myeloma outcomes

Terrell Coring, Jian Wu, Shaima Jabbar, Xiaobei Wang, Cristina Gasparetto, Ken H. Young, Yubin Kang

Blood (2025) 146 (Supplement 1): 7485.

https://doi.org/10.1182/blood-2025-7485

Published: 2025

Journal Articles

Efficacy and safety of Golidocitinib-based first line regimen in peripheral T-cell lymphoma: A multicenter retrospective study

Zhumei Zhan, Peipei Li, Xianghua Wang, Changqing Zhen, Junqing Xu, Jie Yu, Ji Ma, Beibei Lv, Xin Liu, Ken H. Young, Xiaosheng Fang

Blood (2025) 146 (Supplement 1): 7157.

https://doi.org/10.1182/blood-2025-7157

Published: 2025

Journal Articles

The efficacy and safety of polatuzumab vedotin-based regimens in the treatment of diffuse large B-cell lymphoma: A retrospective real-world study

Shunfeng Hu, Beibei Lv, Ken H. Young, Xiaosheng Fang

Blood (2025) 146 (Supplement 1): 7199.

https://doi.org/10.1182/blood-2025-7199

Published: 2025

Journal Articles

P2rx7 in AML blasts orchestrates myeloid differentiation through T cell-mediated visfatin and lymphotoxin signaling

Yunqing Liu, Hui Yuan, Hanheng Mai, Tan Sang, Zonghong Li, Wenyu Peng, Ken H. Young, Lili Feng

Blood (2025) 146 (Supplement 1): 5023.

https://doi.org/10.1182/blood-2025-5023

Published: 2025

Journal Articles

Multi-endpoint AI morphology model (MEAM) enhances risk prediction for vascular events and disease progression in MPNs

Blood (2025) 146 (Supplement 1): 5599.

https://doi.org/10.1182/blood-2025-5599

Published: 2025

Journal Articles

Machine learning models improve survival prediction in DLBCL: Analysis from the goya trial

Shuna Yao, Zian Lin, Bo Yang, Qingyao Shang, Binliang Liu, Meishuo Ouyang, Zhihua Yao, Yanyan Liu, Ken H. Young, Sheng Luo

Blood (2025) 146 (Supplement 1): 3564.

https://doi.org/10.1182/blood-2025-3564

Published: 2025

Journal Articles

Hi-c FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 3529.

https://doi.org/10.1182/blood-2025-3529

Published: 2025

Journal Articles

Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation

Wei Li, Ruirui Wang, Junhao Wang, Dafei Chai, Xiaohui Xie, Ken H. Young, Ya Cao, Yong Li, Xinfang Yu

Blood (2025) 145 (10): 1047–1060.

https://doi.org/10.1182/blood.2024026781

Published: 2025

Includes: Supplemental data

Journal Articles

Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma

Joseph E. Jabbour, Denái R. Milton, Alison M. Gulbis, Bofei Wang, Fadi G. Haddad, Celina Ledesma, Richard E. Champlin, Padmanee Sharma, Ken H. Young, Issa F. Khouri

Blood (2024) 144 (Supplement 1): 7250.

https://doi.org/10.1182/blood-2024-203392

Published: 2024

Journal Articles

Neuronal-Glial and Immune Microenvironment Signatures Show Prognostic Effects in Primary CNS Lymphoma

Blood (2024) 144 (Supplement 1): 4361.

https://doi.org/10.1182/blood-2024-201598

Published: 2024

Journal Articles

Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 429.

https://doi.org/10.1182/blood-2023-179972

Published: 2023

Journal Articles

Research on Different Compound Combinations of Realgar-Indigo Naturalis Formula to Reverse APL Arsenic Resistance By Regulating Autophagy through mTOR Pathway

Ruibai Li, Yiming Pan, Chengyuan Xue, Guangda Li, Jieya Wu, Jingfang Zhang, Yayue Zhang, Jing Wang, Xinyi Chen, Ken H. Young, Li Hou

Blood (2023) 142 (Supplement 1): 5960.

https://doi.org/10.1182/blood-2023-181340

Published: 2023

Journal Articles

Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration

Blood (2023) 142 (Supplement 1): 6079.

https://doi.org/10.1182/blood-2023-178366

Published: 2023

Journal Articles

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Wei Guo, Xiaomeng Feng, Yinping Wang, Jia Li, Yangzhi Zhao, Limei Qu, Xu Yan, Junna Li, Qiang Guo, Ken H. Young, Ou Bai

Blood (2021) 138 (Supplement 1): 4563.

https://doi.org/10.1182/blood-2021-147695

Published: 2021

Journal Articles

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Wei Guo, Yangzhi Zhao, Xingtong Wang, Jia Li, Qiang Guo, Junna Li, Ken H. Young, Ou Bai

Blood (2021) 138 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2021-152164

Published: 2021

Journal Articles

Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms

Blood (2021) 138 (Supplement 1): 2395.

https://doi.org/10.1182/blood-2021-148841

Published: 2021

Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Blood (2021) 138 (6): 452–463.

https://doi.org/10.1182/blood.2020010637

Published: 2021

Includes: Supplemental data

Journal Articles

MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis

Xinfang Yu, Wei Li, Qipan Deng, Haidan Liu, Xu Wang, Hui Hu, Ya Cao, Zijun Y. Xu-Monette, Ling Li, Mingzhi Zhang, Zhongxin Lu, Ken H. Young, Yong Li

Blood (2021) 137 (12): 1615–1627.

https://doi.org/10.1182/blood.2020004918

Published: 2021

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Cytoplasmic but not nuclear cleaved gsdmd expression in live macrophages and DLBCL cells marks proinflammatory cognate interactions rather than pyroptosis and predicts better patient survival in DLBCL

The efficacy and safety of orelabrutinib-based regimens in the treatment of marginal zone lymphoma: A retrospective real-world study

Race-related molecular differences in SLAMF7 expression drive disparities in multiple myeloma outcomes

Efficacy and safety of Golidocitinib-based first line regimen in peripheral T-cell lymphoma: A multicenter retrospective study

The efficacy and safety of polatuzumab vedotin-based regimens in the treatment of diffuse large B-cell lymphoma: A retrospective real-world study

P2rx7 in AML blasts orchestrates myeloid differentiation through T cell-mediated visfatin and lymphotoxin signaling

Multi-endpoint AI morphology model (MEAM) enhances risk prediction for vascular events and disease progression in MPNs

Machine learning models improve survival prediction in DLBCL: Analysis from the goya trial

Hi-c FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma

Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation

Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma

Neuronal-Glial and Immune Microenvironment Signatures Show Prognostic Effects in Primary CNS Lymphoma

Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma

Research on Different Compound Combinations of Realgar-Indigo Naturalis Formula to Reverse APL Arsenic Resistance By Regulating Autophagy through mTOR Pathway

Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only